Skip to main content
Clinical Trials/ACTRN12608000053325
ACTRN12608000053325
Recruiting
Phase 3

A multi-centre, randomised controlled trial of the effect of early goal-directed therapy, compared to standard care, on 90-day mortality in patients presenting to the Emergency Department with severe sepsis in Australasia

Australian and New Zealand Intensive Care Research Centre0 sites1,600 target enrollmentJanuary 29, 2008

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Australian and New Zealand Intensive Care Research Centre
Enrollment
1600
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 29, 2008
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Suspected or confirmed infection
  • 2\. 2 or more systemic inflammatory response syndrome (SIRS) criteria
  • 3\. Evidence of either refractory hypertension or hypoperfusion

Exclusion Criteria

  • Contra\-indication to superior vena cava central venous catheter insertion; contra\-indication to blood products; inability to commence delivery of EGDT protocol within 1 hour of randomisation or complete 6 hours of EGDT; haemodynamic instability due to active bleeding; pregnancy; transfer from another ED or acute health care facility; the patient has an underlying disease process with a life expectancy of \< 90 days; death is deemed imminent and inevitable; a limitation of therapy order has been documented

Outcomes

Primary Outcomes

Not specified

Similar Trials